GoodRx Holdings, Inc.
GDRX
Price:
$7.71
Market Cap:
$2.93B
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2020-09-23
Stock Exchange
NASDAQ
Ticker
GDRX
The ROE as of September 2024 (TTM) for GoodRx Holdings, Inc. (GDRX) is -7.97%
According to GoodRx Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -7.97%. This represents a change of 360.69% compared to the average of -1.73% of the last 4 quarters.
GoodRx Holdings, Inc. (GDRX) Historical ROE (quarterly & annually)
How has GDRX ROE performed in the past?
The mean historical ROE of GoodRx Holdings, Inc. over the last ten years is -20.68%. The current -7.97% ROE has changed -61.45% with respect to the historical average. Over the past ten years (40 quarters), GDRX's ROE was at its highest in in the June 2023 quarter at 6.57%. The ROE was at its lowest in in the December 2020 quarter at -41.93%.
Average
-20.68%
Median
-5.05%
Minimum
-95.87%
Maximum
-1.16%
GoodRx Holdings, Inc. (GDRX) ROE by Quarter and Year
Discovering the peaks and valleys of GoodRx Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 579.68%
Maximum Annual ROE = -1.16%
Minimum Annual Increase = -92.64%
Minimum Annual ROE = -95.87%
| Year | ROE | Change |
|---|---|---|
| 2023 | -1.16% | -71.11% |
| 2022 | -4.03% | 32.68% |
| 2021 | -3.04% | -92.64% |
| 2020 | -41.28% | 579.68% |
| 2019 | -6.07% | 61.20% |
| 2018 | -3.77% | -63.28% |
| 2017 | -10.26% | -89.30% |
GoodRx Holdings, Inc. (GDRX) Average ROE
How has GDRX ROE performed in the past?
The current ROE of GoodRx Holdings, Inc. (GDRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.74%
5-year avg
-11.12%
10-year avg
-20.68%
GoodRx Holdings, Inc. (GDRX) ROE vs. Peers
How is GDRX’s ROE compared to its peers?
GoodRx Holdings, Inc.’s ROE is greater than Teladoc Health, Inc. (-47.82%), greater than Talkspace, Inc. (-6.52%), greater than Accolade, Inc. (-20.30%), less than Doximity, Inc. (18.09%), less than Veeva Systems Inc. (12.89%), less than Progyny, Inc. (11.97%), greater than 10x Genomics, Inc. (-32.74%), greater than Definitive Healthcare Corp. (-50.15%), less than National Research Corporation (63.64%), greater than Evolent Health, Inc. (-6.98%), less than Simulations Plus, Inc. (5.51%), less than Privia Health Group, Inc. (2.62%), greater than Schrödinger, Inc. (-38.38%), greater than American Well Corporation (-70.62%), less than GE HealthCare Technologies Inc. (21.44%), greater than Certara, Inc. (-7.50%), greater than NextGen Healthcare, Inc. (-1.50%), greater than Health Catalyst, Inc. (-23.63%), less than HealthStream, Inc. (5.19%),
| Company | ROE | Market cap |
|---|---|---|
| -47.82% | $1.29B | |
| -6.52% | $301.10M | |
| -20.30% | $322.43M | |
| 18.09% | $6.75B | |
| 12.89% | $34.90B | |
| 11.97% | $2.09B | |
| -32.74% | $2.60B | |
| -50.15% | $503.63M | |
| 63.64% | $518.25M | |
| -6.98% | $3.55B | |
| 5.51% | $690.27M | |
| 2.62% | $2.23B | |
| -38.38% | $1.49B | |
| -70.62% | $118.88M | |
| 21.44% | $38.86B | |
| -7.50% | $1.83B | |
| -1.50% | $1.61B | |
| -23.63% | $440.83M | |
| 5.19% | $861.77M |
Build a custom stock screener for GoodRx Holdings, Inc. (GDRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GoodRx Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
GoodRx Holdings, Inc. (GDRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like GoodRx Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is GoodRx Holdings, Inc.'s ROE?
How is the ROE calculated for GoodRx Holdings, Inc. (GDRX)?
What is the highest ROE for GoodRx Holdings, Inc. (GDRX)?
What is the 3-year average ROE for GoodRx Holdings, Inc. (GDRX)?
What is the 5-year average ROE for GoodRx Holdings, Inc. (GDRX)?
How does the current ROE for GoodRx Holdings, Inc. (GDRX) compare to its historical average?